Drugs / Wistar Rabies Virus Strain PM-1503-3M Vaccine
Wistar Rabies Virus Strain PM-1503-3M Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04410900 | Aug 2020 → Apr 2025 | B-cell neoplasm | Fred Hutchinson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wistar Rabies Virus Strain PM-1503-3M Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04410900 ↗ |
| Modality | Vaccine | “inactivated rabies virus vaccine” NCT04410900 ↗ |
| Route | Intramuscular | “Given IM” NCT04410900 ↗ |